Duplicate Subjects In Clinical Trials Cause Safety & Data Quality Issues

Duplicate subjects in clinical trials

Duplicate subjects in clinical trials result in safety and data quality issues.  The global Verified Clinical Trials research subject database registry system is used around the world to prevent duplicate subjects in clinical trials.  Typical higher risk clinical trials can see double digit incidence rates of protocol violations that will be prevented by Verified Clinical Trials (VCT). VCT will save significant sums of money for Bothe sponsor, CRO and the site.  By preventing duplicate subjects from entering the trial at the time of screening and throughout the entire duration of the study, VCT improved data quality and reduces placebo rates.